Clinical trial
ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159
NCT00168168 is registered in ClinicalTrials.gov with Alberta Health services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159
- Lead sponsor
- Alberta Health services
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- February 28, 2007
- Enrollment
- 60
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral stem cell/marrow transplant